The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany

por Kohli, Michele A., Maschio, Michael, Cartier, Shannon, Mould-Quevedo, Joaquin, Fricke, Frank-Ulrich
Publicado 2022

The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom

por Kohli, Michele A., Maschio, Michael, Mould-Quevedo, Joaquin F., Drummond, Michael, Weinstein, Milton C.
Publicado 2021

The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom

por Kohli, Michele A., Maschio, Michael, Mould-Quevedo, Joaquin F., Ashraf, Mansoor, Drummond, Michael F., Weinstein, Milton C.
Publicado 2021

An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom

por Maschio, Michael, Kohli, Michele A., Ashraf, Mansoor, Drummond, Michael F., Weinstein, Milton C., Mould-Quevedo, Joaquin F.
Publicado 2022